Background During the United Kingdom Prospective Diabetes Study (UKPDS), patients with type 2 diabetes mellitus who received intensive glucose therapy had a... Read more

Enter part of a product's name and a list of options will be closest to the name of the medicine required to show
Company history: BioMed Pharma is one of the leading companies in the pharmaceutical industry in Syria. Since its inception in 2007, BioMed Pharma has been a high-quality pharmaceutical manufacturer with similar qualities to foreign medicines, which guarantees excellent efficacy in treating various chronic diseases. BioMed Pharma has earned the trust of both the doctor and the patient because of its quality manufacturing equipment, high efficiency materials, and the safety of transferring scientific information. Company Profile: Since its inception, the company aims to produce high quality medicines with high quality specifications covering the Syrian market in various diseases, especially chronic diseases. The company's factory is located...
MoreBackground During the United Kingdom Prospective Diabetes Study (UKPDS), patients with type 2 diabetes mellitus who received intensive glucose therapy had a... Read more
Vitamin C and zinc play important roles in nutrition, immune defence and maintenance of health. Intake of both is often... Read more
Study objective: To determine whether single preoperative administration of 2 different doses of pregabalin (75 and 150 mg) could decrease postoperative... Read more
BACKGROUND Sodium–glucose cotransporter 2 (SGLT2) inhibitors reduce the risk of hospitalization for heart failure in patients regardless of the presence or... Read more
BACKGROUND Previous trials have shown that the use of statins to lower cholesterol reduces the risk of cardiovascular events among persons without... Read more
... Read more